TIAA CREF Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $7.07M | Sell |
384,160
-163,397
| -30% | -$3.01M | 0.01% | 1237 |
|
|
2018
Q4 | $14.3M | Sell |
547,557
-179,466
| -25% | -$4.69M | 0.01% | 790 |
|
|
2018
Q3 | $16.7M | Buy |
727,023
+41,687
| +6% | +$957K | 0.01% | 818 |
|
|
2018
Q2 | $13.1M | Buy |
685,336
+169,254
| +33% | +$3.22M | 0.01% | 985 |
|
|
2018
Q1 | $8.7M | Buy |
516,082
+69,600
| +16% | +$1.17M | 0.01% | 1200 |
|
|
2017
Q4 | $6.79M | Buy |
446,482
+21,595
| +5% | +$328K | ﹤0.01% | 1411 |
|
|
2017
Q3 | $7.61M | Buy |
424,887
+115,205
| +37% | +$2.06M | 0.01% | 1326 |
|
|
2017
Q2 | $5.05M | Sell |
309,682
-99,270
| -24% | -$1.62M | ﹤0.01% | 1597 |
|
|
2017
Q1 | $5.73M | Buy |
408,952
+19,674
| +5% | +$275K | ﹤0.01% | 1508 |
|
|
2016
Q4 | $6.21M | Buy |
389,278
+10,314
| +3% | +$165K | ﹤0.01% | 1463 |
|
|
2016
Q3 | $6.31K | Buy |
378,964
+80,191
| +27% | +$1.33K | ﹤0.01% | 1442 |
|
|
2016
Q2 | $3.34M | Buy |
298,773
+87,527
| +41% | +$979K | ﹤0.01% | 1814 |
|
|
2016
Q1 | $1.77M | Buy |
211,246
+76,700
| +57% | +$641K | ﹤0.01% | 2148 |
|
|
2015
Q4 | $1.25M | Hold |
134,546
| – | – | ﹤0.01% | 2452 |
|
|
2015
Q3 | $1.52M | Buy |
134,546
+5,431
| +4% | +$61.3K | ﹤0.01% | 2312 |
|
|
2015
Q2 | $1.64M | Buy |
129,115
+866
| +0.7% | +$11K | ﹤0.01% | 2422 |
|
|
2015
Q1 | $1.19M | Sell |
128,249
-375,446
| -75% | -$3.49M | ﹤0.01% | 2520 |
|
|
2014
Q4 | $7.21M | Sell |
503,695
-3,807
| -0.8% | -$54.5K | 0.01% | 1363 |
|
|
2014
Q3 | $5.27M | Sell |
507,502
-27,801
| -5% | -$289K | ﹤0.01% | 1573 |
|
|
2014
Q2 | $8.66M | Buy |
535,303
+102,025
| +24% | +$1.65M | 0.01% | 1265 |
|
|
2014
Q1 | $7.04M | Sell |
433,278
-16,116
| -4% | -$262K | 0.01% | 1365 |
|
|
2013
Q4 | $5.58M | Sell |
449,394
-39,396
| -8% | -$489K | ﹤0.01% | 1562 |
|
|
2013
Q3 | $5.36M | Buy |
488,790
+8,361
| +2% | +$91.7K | ﹤0.01% | 1537 |
|
|
2013
Q2 | $3.88M | Buy |
+480,429
| New | +$3.88M | ﹤0.01% | 1706 |
|